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ABSTRACT 
 
 Huge progress has been made in the development of three dimensionally printed 
tissue structures. With the use of cells, three dimensional printers, and CAD drawing 
software, donor identical structures can be fabricated. However, cell scaffolds currently 
lack significant mechanical integrity which can result in reduced cellular survival, 
attachment, and nutrient delivery. For this reason, multiple strategies have been developed 
to increase and improve mechanical stability within engineered constructs without having 
to sacrifice cell viability. 
The hypothesis of this paper was that incorporating Perfluorotributylamine 
(PFTBA), a greenhouse gas, with single walled carbon nanotubes (SWCNT), a allotrope 
of carbon with a cylindrical nanostructure, into an alginate scaffold will not only increase 
mechanical integrity but also cell survival. The following objectives were proposed: 1. 
Fabricate and characterize cell laden scaffolds of alginate and 2. Assess the addition of 
perfluorotributylamine and various concentrations of carbon nanotubes inside of cell laden 
scaffolds of alginate. Three configurations of perfluorotributylamine and carbon 
nanotubes were explored in an effort to maximize mechanical properties and 
cytocompatibility. Perfluorotributylamine was combined with gelatin from bovine skin 
and phosphate buffered solution to form a PFTBA emulsion. This emulsion was added to 
each alginate scaffold to encompass 5% of the entire alginate scaffold. Single walled 
carbon nanotubes were added in increasing concentrations to have four scaffolds, one 
control, 0 µg/ml, .1 µg/ml, and 1 µg/ml. The results of this study indicate that the 
configuration of 5% PFTBA emulsion + 1 µg/ml SWCNT + alginate, provided the best 
cell viability results; Picogreen fluorescence of 8532, excellent viability in live/dead stain, 
and sufficient morphological features while the control scaffold, containing alginate only, 
provided the best mechanical properties after a 7 day period. The results contradict the 
hypothesis that mechanical properties will increase with increasing SWCNT 
concentration, but support the hypothesis of improved cell viability with the incorporation 
of PFTBA emulsion to increasing SWCNT concentration.
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1. INTRODUCTION 
 
1.1    Overview of Thesis 
The first chapter introduces the history of three dimensional printing and its 
modification to the process of bioprinting living cells. It mentions research into currently 
used engineered scaffolds and its application in organ transplantation surgeries. Chapter 2 
reviews recent literature for the currently used hydrogels with their advantages and 
disadvantages, the chosen hydrogel used in this research, the additives used with the 
intention of increasing cell viability and mechanical properties. Chapter 3 details the in 
vitro three dimensional print fabrications and analysis of the various scaffold 
configurations. Chapter 4 concludes this thesis and provides direction for future research 
to better the development of engineered scaffolds. 
 
1.2    History of Three Dimensional Printing 
The idea of mass replication and production has been around for many centuries. 
With recent advancements in technology over the last couple of years, additive 
manufacturing has transformed from the production of two dimensional shapes into that 
of three dimensional. Rapid production of three dimensional shapes helped to increase 
the production speed of various products such as jewelry, electronics, and plastics in 
various industries such as automotive, aviation, and manufacturing. [1] In 1986, Charles 
W. Hull first depicted three dimensional (3D) printing as a method, deemed 
stereolithography, where thin layers of material were consecutively printed to form a 
solid three dimensional structure that was cured with ultraviolet light.  [2] This process 
was later modified to create sacrificial resin molds that would form three dimensional 
scaffolds from biological materials. [1] 
 
1.3    Three Dimensional Bioprinting 
Bioprinting is a computer-aided manufacturing technique that allows the 
construction of structures layer by layer using biological materials, biochemicals, and 
living cells, with spatial control of functional components. [1] A bioprinter is constituted 
of a computer-aided positioning and deposition system, a bioink that feeds the deposition 
system, and a biopaper that acts as the substrate for the deposition. The computer controls 
the placing apparatus by moving the sample or the deposition heads along a 
predetermined path, initiating the deposition of the bioink when needed. Bioprinting is 
based on three approaches which include; biomimicry, autonomous self-assembly, and 
mini tissue building blocks. [1] Biomimicry involves the manufacturing of identical 
reproductions of the cellular and extracellular components of a tissue or organ. [3] In 
order to achieve biomimicry, distinct cellular functional components must be duplicated 
on a microscale. An understanding of the microenvironment, including the specific 
arrangement of functional and supporting cell types, gradients of soluble and insoluble 
factors, and composition of the extracellular matrix (ECM) is needed. [1] Autonomous 
self-assembly uses embryonic organ development as a guide. This approach relies on the 
cell as the primary driver of histogenesis, directing the composition, localization, 
functional, and structural properties of the tissue. [4, 5] The last approach, mini tissues 
can be fabricated and assembled into larger tissues by driven design, self-assembly, or a 
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combination. There are two strategies within mini tissues, self- assembling cell spheres 
which are assembled into large tissue and accurate, high-resolution reproductions of a 
tissue unit which are designed and then allowed to self-assemble into larger tissue. 
[6,7,8,9] Fabrication of these 3D biological structures are manufactured using various 
types of micro-extrusion printers, computer aided design software, and mathematical 
modeling to collect and digitize the complex tomographic and architectural design of the 
proposed tissue structure. Current bioprinting technologies are divided into three types of 
printers, which are, inkjet, microextrusion, and laser-assisted.  
 
1.3.1 Microextrusion Bioprinter 
Microextrusion bioprinters are the most common and affordable of the three 
types. These printers are more commonly used in personal and academic institutions with 
higher quality industrial versions that offer better resolution, speed, and spatial control. 
[10] Microextrusion bioprinters have been used to fabricate various tissue types, such as, 
aortic valves, branched vascular trees, as well as tumor models [1]. Material is deposited 
in continuous beads of material rather than liquid droplets. The three types of 
microextrusion bioprinters are pneumatic, piston, and screw dispensing systems, the last 
two of which are deemed mechanical. [11, 12, 13] Pneumatic dispensers are 
advantageous due to simpler drive-mechanism components, with the force limited only 
by the air-pressure capabilities of the system, suited to dispense high-viscosity materials. 
One disadvantage includes less control of flow due to the delay of the compressed gas 
volume. Mechanical dispensing systems have smaller and more complex components 
which offer more spatial control over the material flow, and are thought to be beneficial 
for the dispensing of hydrogels with higher viscosities. [14] These benefits often result in 
reduced maximum force capabilities. 
The main advantage of microextrusion bioprinting technology is the ability to 
deposit very high cell densities. Achieving physiological cell densities in tissue-
engineered organs is a major goal for the bioprinting field. Cell viability after 
microextrusion bioprinting is in the range of 40–86%, depending on extrusion pressure 
and nozzle gauge. [15,16] Use of improved biocompatible materials, such as hydrogels, 
that are mechanically robust during printing and that develop secondary mechanical 
properties after printing can improve cell viability and function after the printing process. 
[17, 18] 
 
1.4    Engineered Scaffolds 
Tissue engineering aspires to devise ways to artificially produce organs and tissue 
structures in the human body. In 3D printing, layer by layer precise positioning of 
biological materials, biochemical and living cells, with spatial control of the placement of 
functional components, are used to fabricate 3D structures in the form of scaffolds. [1] 
The field of bioprinting also faces other challenges shared by all researchers in the fields 
of tissue engineering and regenerative medicine. The central challenge is to reproduce the 
complex micro-architecture of extracellular matrix (ECM) components and multiple cell 
types in sufficient resolution to repeat biological function. [1] Another challenge in the 
3D bioprinting field has been to find materials that are not only compatible with 
biological materials and the printing process but can also provide the desired mechanical 
and functional properties for tissue constructs. 
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1.5     Description of the Need for Engineered Scaffolds 
The most popular treatment for loss or damaged tissues and organs is organ 
transplantation. According to the U.S. Department of Health and Human Services 
(DHH), an average of 21 patient deaths occur each day waiting for transplants that cannot 
take place due to the shortage of donated organs. [19] Thus there is a significant need for 
improved techniques to combat the reproduction and repair of various organs as they fail 
or become obsolete. The concept of complete organ reproduction is in infancy however; 
the research surrounding producing a patient’s own cells in the form of hydrogel scaffold 
is a stepping stone to reach this goal.  
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2. LITERATURE REVIEW 
 
2.1 Hydrogels for Tissue Engineering  
Drury et al. provides a thorough review of the various hydrogels used for tissue 
engineering applications. There are various strategies used to engineer tissues that depend 
on incorporating a material scaffold. These scaffolds are used to mimic the extracellular 
matrix so that cells can be distributed into a three-dimensional architecture to properly 
grow and form the intended tissue. [20] In order to produce these scaffolds, a class of 
highly hydrated polymer materials with water content greater than 30% by weight 
deemed hydrogels, are being used. These hydrogels are made up of natural and synthetic 
hydrophilic polymer chains which have similar characteristics to tissues and ECM. [21] 
Selection between these two types of hydrogels is dependent upon several factors such as 
rate of gel formation, nutrient diffusion, and cell adhesion.  
 
2.1.1  Synthetic hydrogels 
The use of synthetic hydrogels in tissue engineering is due to their customizable 
chemistry and properties. Synthetic hydrogels can be manufactured with various 
molecular weights, chain linkages, and solidification methods which can factor into the 
material mechanical properties and formation methods. [20] Examples of such material 
include, PEO, PEG, PVA, and PLA. 
 
2.1.2  Natural hydrogels 
Natural hydrogels are polymers that are made up of components that are either a 
part of or have molecular properties similar to that of natural ECM. These materials 
include but are not limited to collagen, HA, alginate, and chitosan. 
 
a Sodium Alginate 
Alginate is non-biodegradable, bio-inert, and biocompatible material derived from 
brown seaweed and bacteria. It is a hydrophilic, linear polysaccharide of (1–4)-linked ?-
D-mannuronic acid (M) and α-L-guluronic acid (G) monomers which are distributed in 
either repeating or alternating blocks. [22, 23, 24] Alginate is normally combined with 
water or a saline to produce a solution which forms a gel when divalent cations such 
as Ca2+, Ba2+, or Sr2+ cooperatively interact with blocks of G monomers to form ionic 
bridges between different polymer chains. [22] Following cross linkage, Alginate 
undergoes a slow, uncontrolled dissolution with mass loss by ion exchange of calcium 
resulting in the dissociation of individual chains and loss of mechanical integrity. 
 
A solution to this can greatly enhance cell viability and hydrogel life.[25] The most 
commonly used divalent cation with alginate is Ca2+ , normally used in the form of 
Calcium Chloride. Alginate has been proven to be a compatible material with a variety of 
uses including drug delivery, cell encapsulation, and in vivo which encourages its use in 
tissue engineering.  
 F
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With the incorporation of carbon nanotubes into alginate hydrogels, cell viability 
and proliferation could be increased and the mechanical structure of these constructs 
could be greatly extended and potentially strengthened. This concept should be further 
explored as a method for newly printed tissue constructs.  
 
2.2.1 Carbon Nanotube Functionalization 
Carbon nanotubes are naturally chemically inert and dispense unevenly in various 
polymers. In order to improve biocompatibility and increase the ability to disperse 
evenly, functionalization is required in order to incorporate carbon nanotubes into 
polymers. [41] Functionalization normally involves the addition of carboxyl or alcohol 
groups to the ends of the nanotubes. The bonds formed between the carbon nanotubes 
and functional groups are useful in tissue engineering because they are weak enough to 
allow various reactions to take place within the biochemical environment, but not too 
weak to prevent rapid chemical decay.[42,43] Similar to size, functional groups can have 
an effect on cell growth and differentiation. Charged carboxyl groups have shown 
increased chondrocyte growth and ECM protein expression. [44] Recent results also have 
shown that when functionalizing carbon nanotubes with nitric and sulphuric acids, 
functionalization periods of 5 hours compared to .5 hours, increase cell viability. [45] 
 
2.3 Perfluorocarbons 
Perfluorocarbons (PFCs) are nonaqueous, cytocompatible, and highly oxygenated 
fluids. These hydrocarbons have fluorine substituted in place of most or all hydrogen 
atoms, an increased molecular mass, and also specific gravities twice that of water. [46] 
Due to the carbon to fluorine bond strength, 487 kJ mol -1, PFCs have noteworthy 
chemical and thermal stability, great spatial arrangement, and the ability to dissolve large 
quantities of respiratory gases [46]. These solutions have been previously used in 
research by Clark and Gollan to test and confirm the survival of small mice fully 
submerged in fluorobutyltetrahydrofuran. [46] More recently, research has shown that the 
incorporation of these solutions with bioreactors and cell cultures resulted in higher cell 
proliferation and cell bioproduct assembly. Various studies using PFC emulsions have 
also been conducted for use in preserving human and animal organs before 
transplantation. [47, 48] 
 
2.3.1 Addition of Perfluorotributylamine  
Perfluorotributylamine (PFTBA) is a type of perfluorocarbon useful with cell and 
organ printing due to its inert properties. Perfluorotributylamine has a density of 1.88 g 
cm-3, approximately twice the density of water.  [49] One of the ideal benefits of 
Perfluorotributylamine is that is hydrophobic, which makes it non-miscible leading to 
aided mechanical support of printed scaffolds during the three dimensional fabrication 
process. Campos et al previously conducted study where stem cell laden agarose 
hydrogel scaffolds were printed a Perfluorotributylamine solution. Results showed 
excellent improvement in compressive strength, excellent cell viability after 24 hours and 
21 days, and increased cell proliferation using stem cells.  
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Studies have also demonstrated the use of a PFTBA emulsion, composed of 
PFTBA, lecithin, and Phosphate Buffered Saline, increasing oxygen levels within cellular 
scaffolds which in turn increase gene expression, cell viability, nerve cell regeneration, 
osteogenic differentiation, and bone formation in vivo. [50, 51, 52]  
 
2.4 Future Work 
From this review, alginate hydrogel, carbon nanotubes, and PFTBA, all 
commonly used in tissue engineering were presented and reviewed. During this process 
of examining the many benefits in cell viability and mechanical integrity of these 
materials, more research will need to be done to show appropriate configurations and 
concentrations of these materials in vitro and in vivo. More extensive lab trials and 
animal trials, which will eventually lead to human trials, will need to be done to provide 
the date for clinical use.  
 
2.5 Conclusion 
The use of alginate hydrogels, carbon nanotubes, and PFTBA,  have had notable 
occurrences in laboratory use and all have a potential to be further developed for clinical 
use in the field of tissue engineered scaffolds. As the need for organ transplants is 
increased, the need for alternatives to shortages will continue to rise. Due to the 
revolutionary advancements in technology and medicine, there has never been a better 
time to continually improve the current knowledge of three dimensionally printed 
biological scaffolds.  This search for improvement has led to many additives being 
experimented with to research if they are able to improve the biological properties of 
current hydrogel solutions. These additions to current hydrogel configurations have led to 
many developments in aiding three dimensionally printed organ developments, improved 
mechanical strength of scaffold models, improved cellular viability and proliferation, and 
increased knowledge of tissue engineering. The additives reviewed here have led to 
bettering the current understanding of three dimensional scaffolds and additives for tissue 
engineering experiments. With further research on the combinations of these materials in 
vitro, in vivo, and clinically, much advancement within the field are on the horizon. 
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3.  IN VITRO EVALUATION OF THREE DIMENSIONALLY PRINTED 
PERFLUOROTRIBUTYLAMINE AND CARBON NANOTUBE ENRICHED 
ALGINATE SCAFFOLD 
 
3.1  Project Purpose 
Due to the large number of organ transplant surgeries occurring each year and 
with these procedures projected to increase, there is a need to discover a more effective 
alternative to organ transplantation. The idea of customizable, patient exact organ 
production is a novel concept currently being worked towards through three dimensional 
printing, hydrogels, and human cells and their production to form tissue engineered 
scaffolds. There is a need for researchers to become more efficient and gain better control 
over the production process, especially regarding cellular viability and mechanical 
stability. Current research has shown that these scaffolds lack in mechanical integrity and 
life of implanted cells. Poor mechanical integrity can result in poor gas exchange and can 
even play a factor in reduced viability of implanted cells. This study explored several 
compositions of single walled carbon nanotubes and a emulsion made with 
perfluorocarbon, phosphate buffered saline and gelatin from bovine skin. The 5% PFTBA 
emulsion + 1 µg/ml SWCNT + alginate, provided the best cell viability results; Picogreen 
fluorescence of 8532, excellent viability in live/dead stain, and sufficient morphological 
features while the control scaffold, containing alginate only, provided the best 
mechanical properties. This composition may have application as an improvement with 
hydrogels and could be further explored. 
 
3.2 Materials and Methods 
Sodium Alginate and Calcium Chloride (Sigma Aldrich, U.K.) were treated with 
ultraviolet (UV) light for sterilization three times for a 30-minute cycle each time. UV-
sterilized sodium alginate was dissolved in sterile Phosphate Buffer Saline (PBS) to make 
2% (w/v) solutions.  Similarly, the crosslinking solution was prepared by dissolving UV-
sterilized Calcium Chloride particles in sterile Dulbecco’s Modified Eagle Medium 
(DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% triple antibiotic 
achieving 4% (w/v). Solutions were mixed with a magnetic stirrer at room temperature 
until homogeneity was reached. To eliminate any remaining contaminant, both solutions 
were passed through a filter with a pore size of 0.22 µm.  
      3.2.1 Carbon nanotube Functionalization 
Single Walled Carbon Nanotubes were obtained in powder form from US 
Research Nanomaterials, Inc. (Stock#: US 4110) with average diameter 1.1 nm and a 
length of 5- 30 µm. The purity of SWCNTs used was >90%. 30 mg of pure SWCNTs 
was dispersed in 60 mL of 1:3 mixture of 98% nitric acid (HNO3) and 70% sulfuric acid 
(H2SO4) in a round bottom flask equipped with a condenser and refluxed for 180 
minutes at 120°C while stirring at a rate of 500 rpm as shown in figure 3.1. [45] 
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3.2.2 Dispersion of Carbon Nanotubes 
The preparation of carbon nanotubes in Dulbecco’s Modified Eagle Medium 
(DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% triple antibiotic used 
a sonication/centrifugation protocol described by Chin et. al. [53] Briefly, 1 mg of 
functionalized SWCNT powder was dispensed into an Eppendorf tube containing 1 ml of 
DMEM/FBS, vortexed for 1 min and sonicated for 10 min at 0 degrees Celsius. The 
resulting suspension was centrifuged in an Eppendorf tube for 2 minutes at 16,000 g. The 
supernatant was carefully recovered to produce a DMEM-SWCNT dispersion.  
3.2.3 Perfluorotributylamine Emulsion Preparation 
A PFTBA emulsion was prepared in the following manner. 95 mg of gelatin from 
bovine skin  and 400 µL PFTBA was added to 600 µL of phosphate buffered solution.[50, 
51, 52] The solution was sonicated at 4 °C twelve times for 15 seconds with a 1 minute 
interval between each sonication.  
The mixture was then reheated in a water bath of 37 °C and vortexed before 
usage. The PFTBA emulsion was sterilized by filtering through a .22 µm membrane filter 
and treated with UV light for sterilization three times for a 30-minute cycle each time.  
3.2.4 Cell Culture  
NIH 3T3 mouse fibroblast from passages 14 to 27 were cultured in Dulbecco’s 
Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 
1% triple antibiotic in 25 cm2 tissue culture flasks. All cells were incubated at 37°C and 
5% CO2. The media was changed in each flask every 3 days and passaged at 80% 
confluence. 
 
3.2.5 Scaffold Fabrication 
Mouse fibroblast cells were resuspended at 250,000 cells/ml in 2% sodium 
alginate by vortexing for 10-20 seconds. Alginate with Mouse fibroblast cells was taken 
into 20ml syringes and passed through medical tubing to a 20 gauge needle tip. 4% 
Calcium chloride was also taken into a 20 ml syringe passed through medical tubing to a 
22 gauge needle. Both of which were attached to a custom 3D printed face of the 
Reprappro Mendel 3D printer. The Alginate solution syringe was controlled by the 
extruder motor of the printer which was attached to a syringe extruder. This allowed for 
the control of the printing material directly from the printer. The calcium chloride solution 
was extruded at an angle so as to drip down the needle of the alginate. The extrusion was 
controlled by an external syringe pump that was set to 70 ml/h. A 5 mm tall, 4 mm 
diameter cylinder structure was created using a SolidWorks which was then converted to 
g- code through the software Slic3r. The g-code was then loaded to Pronterface. Scaffolds 
were printed in various configurations, incubated for 7 days with media exchanged 3 days 
after print, and tested. The control scaffold contained no carbon nanotubes and no PFTBA 
emulsion. The remaining 3 scaffolds were printed with increasing amounts of carbon 
nanotubes starting at 0 µg/ml to .1 µg/ml and lastly 1 µg/ml with a 5% v/v addition of 
PFTBA emulsion. Scaffolds were printed in triplicates for each experiment.  
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3.3 Cell Viability Studies  
 
3.3.1 Live/Dead Assay 
The 3D cell laden hydrogels were incubated under controlled conditions for 7 
days. The live/dead assay was created using 20µL of EthD-1, 10ml D-PBS, and 5µl 
calcein AU. The prints were moved to a 48 well plate and covered with solution. Images 
were taken using a lumar-stereo microscope. 
 
3.3.2 Picogreen 
The printed structures were incubated and put on a rocker with proteinase K at 
56˚C overnight. 50µl of the solution with 50µl of Picogreen dye were migrated to a 96 
well plate. The samples were exposed to 480nm light, and the total DNA concentration 
was compared to each other.  
3.4 Cell Morphology Studies 
3.4.1 F.Actin Stain 
The printed structures were rinsed with PBS, fixed with 4% paraformaldehyde for 
20 minutes, and rinsed again with PBS. Next the scaffolds were permeabilized with 0.1% 
triton x-100 for 10 minutes and lastly stained with ActinGreen 488 reagent for 30 mins. 
Following the process, the stain was removed; the scaffolds were rinsed with PBS and 
imaged using a confocal microscope.  
3.5 Mechanical Analysis 
Compression testing was performed at room temperature on the structures each 
being 8mm diameter and 10mm in height. This was done using a hydraulic universal 
testing machine (MODEL) using an extension rate of 1 mm min-1. 
3.6 Statistical Analysis 
All results were expressed as a mean ± percent error.  
 
3.7 Results  
 
3.7.1 Live/Dead Stain 
To analyze the 3D scaffolds with respect to cell viability. Mouse fibroblast cells 
were seeded at a density of 250,000 cells per milliliter. The cell images for the mouse 
fibroblast cells revealed excellent cell viability 7 days after the printing process and 
incubation period. As shown if figures 3.5, 3.6, 3.7, and 3.8  
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3.7.2 Picogreen 
For samples undergoing fluorescence analysis, a cell concentration of 250,000 
cells per milliliter was used. The numerical value of the fluorescence tends to directly 
correlate to the numerical value of the actual number of cells counted within each 
scaffold structure. The Picogreen begins with an average of fluorescence of 2611 and 
increases to 4965, 5370, and 8532, for the controls, 5% PFTBA emulsion scaffolds, .1 
µg/ml, and 1 µg/ml scaffolds, respectively, as shown if figure 3.9. The fluorescence 
activity shown in the chart below, of the mouse fibroblast cells, tends to increase from the 
control scaffolds to those with no carbon nanotubes and a 5% pftba emulsion, to those 
with increasing amounts of carbon nanotubes, .1 µg/ml and 1 µg/ml, with  a 5% pftba 
emulsion.  Statistically speaking, there was a 90.157% increase between the control 
scaffolds and the scaffolds containing a 5% pftba emulsion. There was an 8.157% 
increase between the scaffolds containing a 5% pftba emulsion and those containing a 5% 
pftba emulsion and .1 µg/ml carbon nanotube concentrations. Lastly, there was 58.883% 
increase between the scaffolds containing a 5% pftba emulsion and .1 µg/ml carbon 
nanotube concentrations and those containing a 5% pftba emulsion and 1 µg/ml carbon 
nanotube concentrations. 
 
 
 
Figure 3.9: Fluorescence of 3T3 laden hydrogels after 7 days.  
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The tests were performed at room temperature. The mechanical tests revealed a 
vast difference in the stress, strain, and compressive strength between the control and 
combination scaffolds. The Young’s Modulus begins with an average of 12,850 kPa and 
decreases to 2639, 2382, and 1609 kPa, for the controls, 5% PFTBA emulsion scaffolds, 
.1 µg/ml, and 1 µg/ml scaffolds, respectively, as shown in figure 3.14.  
 
 
 
Figure 3.14: Young’s Modulus of 3T3 laden hydrogels after 7 days. The control scaffold 
had significantly higher results than the remaining scaffolds. The remaining scaffolds 
decreased in results, with increasing concentration of SWCNTs.  
 
 
Statistically speaking, there was a 79.459% decrease between the control scaffolds 
and the scaffolds containing a 5% pftba emulsion. There was a 9.747% decrease between 
the scaffolds containing a 5% pftba emulsion and those containing a 5% pftba emulsion 
and .1 µg/ml carbon nanotube concentrations. Lastly, there was 32.469% decrease 
between the scaffolds containing a 5% pftba emulsion and .1 µg/ml carbon nanotube 
concentrations and those containing a 5% pftba emulsion and 1 µg/ml carbon nanotube 
concentrations. The Compressive Stress at Tensile Strength begins with an average of 983 
kPa and decreases to 302, 274, and 246 kPa, for the controls, 5% PFTBA emulsion 
scaffolds, .1 µg/ml and 1 µg/ml scaffolds, respectively, as shown if figure 3.15. 
Statistically speaking, there was a 69.313% decrease between the control scaffolds and the 
scaffolds containing a 5% pftba emulsion. There was a 9.102% decrease between the 
scaffolds containing a 5% pftba emulsion and those containing a 5% pftba emulsion and .1 
µg/ml carbon nanotube concentrations.  
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Lastly, there was 10.462% decrease between the scaffolds containing a 5% pftba 
emulsion and .1 µg/ml carbon nanotube concentrations and those containing a 5% pftba 
emulsion and 1 µg/ml carbon nanotube concentrations. These results are most likely due 
to the incorporation of the PFTBA emulsion.  
 
 
 
Figure 3.15: Compressive Stress of 3T3 laden hydrogels after 7 days. The control 
scaffold had significantly higher results than the remaining scaffolds. The remaining 
scaffolds decreased in results, with increasing concentration of SWCNTs.  
 
 
3.8 Discussion 
Three dimensional cell laden scaffolds are produced through the combination of 
three dimensional bio-plotters and printers, computer assisted design software, hydrogels, 
and various cell types. Cells are infused within hydrogels and are then extruded through 
tubing by the printer to produce computer designed structures. These structures are 
intended to be identical to their computer and organ models, however lack the necessary 
mechanical and chemical features to encourage cellular life once printed. Success with 
cellular scaffolds is due to proper selection of hydrogels and key additives in various 
concentrations. Single walled carbon nanotubes were chosen due to their ability to 
increase mechanical features in three dimensional scaffolds and other biomaterials. The 
incorporation of perfluorotributylamine was also used to increase cell viability due to 
various studies showing its success in tissue formation.  
 This study was conducted to determine the scaffold’s structure as a function of 
alginate hydrogel with an added constant perfluorotributylamine concentration with 
increasing amounts of single walled carbon nanotubes.  
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Four scaffolds concentrations were produced, a alginate control with no single 
walled carbon nanotubes and no perfluorotributylamine, alginate with 5% by weight 
perfluorotributylamine, alginate with 5% by weight perfluorotributylamine and .1 µg/ml 
single walled carbon nanotubes, and alginate with 5% by weight perfluorotributylamine 
and 1 µg/ml single walled carbon nanotubes. 
 Working with the control and the three modified scaffolds, the results display 
high cell viability. Results show increased cell viability with the addition of the 
perfluorotributylamine emulsion and increase with increasing amounts of single walled 
carbon nanotubes. The increased cell viability in the scaffolds containing the 
perfluorotributylamine is believed to have occurred due to the increased oxygen content 
that is normally associated with the addition of perfluorotributylamine and also due to the 
imitated extracellular matrix produced by the single walled carbon nanotubes. 
 The mechanical properties are shown to decrease with the addition of 
perfluorotributylamine and continue to decrease as the carbon nanotube concentration is 
increased, correlating indirectly with the hypothesis. The poor mechanical properties in 
the alginate with 5% by weight perfluorotributylamine, alginate with 5% by weight 
perfluorotributylamine and .1 µg/ml single walled carbon nanotubes, and alginate with 
5% by weight perfluorotributylamine and 1 µg/ml single walled carbon nanotubes 
scaffolds are hypothesized to be due to the addition of perfluorotributylamine. In future 
studies, adjusting the amount of perfluorotributylamine can potentially increase 
mechanical properties.  
 
3.9  Conclusion 
The utilization of three dimensional bio plotting provides an opportunity for 
researchers and engineers to create an alternative method to donor exact organ 
transplantation. This study explored the effect of different concentrations of single walled 
carbon nanotubes added in increasing amounts to a 5% perfluorotributylamine emulsion 
and concluded that the 5% by weight perfluorotributylamine emulsion and 1 µg/ml single 
walled carbon nanotube scaffold displayed the highest cell viability compared to the 
control, alginate with 5% by weight perfluorotributylamine, alginate with 5% by weight 
perfluorotributylamine and .1 µg/ml single walled carbon nanotube scaffolds. The control 
scaffold with a 0 concentration of both single walled carbon nanotubes and 
perfluorotributylamine emulsion displayed the optimal mechanical strength compared to 
the 5% by weight perfluorotributylamine, alginate with 5% by weight 
perfluorotributylamine and .1 µg/ml single walled carbon nanotubes, and alginate with 
5% by weight perfluorotributylamine and 1 µg/ml single walled carbon nanotubes 
scaffolds. Based on these results further studies may prove beneficial to exploring a better 
combination of the proposed components to increase cell viability while also increasing 
or maintaining mechanical properties.  
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4. SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS  
 
4.1  Summary 
Three dimensionally printed constructs are a stepping stone to the application of 
fully printed donor identical organs and tissues. The use of alginate hydrogels cross-
linked with calcium chloride to form three dimensional shapes has been widely 
researched in literature, with various additives and configurations. Within this study of 
the additive benefits of carbon nanotubes and perfluorotributylamine into an alginate 
hydrogel structure formed via a three dimensional bioplotter, various combinations were 
produced with a potential to increase mechanical stability and cellular viability. This 
study is beneficial to the growing need for donor substitutions and patient identical 
constructs which will be immune compatible.  
These scaffold configurations are similar to those widely used in various research 
programs where alginate is the base hydrogel.  
 To study the potential of this theory an in vitro study was conducted to test the 
cytocompatibility, mechanical properties, and the morphological effects on cells as a 
function of the configuration of a perfluorotributylamine addition to increasing 
concentrations of carbon nanotubes within alginate. The alginate only, 5% 
perfluorotributylamine + alginate, 5% perfluorotributylamine + .1 µg/ml carbon nanotube 
+ alginate, and 5% perfluorotributylamine + 1 µg/ml carbon nanotube + alginate 
scaffolds underwent an live/dead assay, Picogreen assay, f-actin stain, and compression 
testing. 
 
4.2  Conclusions 
The results of this study indicate that the configuration of 5% 
perfluorotributylamine + 1 µg/ml carbon nanotube + alginate, provided the best cell 
viability results; Picogreen fluorescence of 8532, excellent viability in live/dead stain, 
and excellent morphological features. The control scaffold, containing alginate only, 
provided the best mechanical integrity compared to the other configurations. This 
provides more insight to the proper configuration between perfluorotributylamine and 
carbon nanotubes within an alginate scaffold to reach a non-toxic, mechanically stable 
structure. The Picogreen fluorescence of the scaffolds increased with increasing carbon 
nanotube concentration while mechanical properties decreased with increasing carbon 
nanotube concentration. Further research into effect on the morphological structure could 
be done.  
 
4.3  Recommendations 
1. Testing various other hydrogels and hydrogel configurations instead of alginate and 
calcium chloride as a cross linking solution with the perfluorotributylamine emulsion and 
single walled carbon nanotube configurations used in this study. This may lead to 
increased mechanical properties.  
2. Testing the incorporation of various other types of perfluorocarbons instead of 
perfluorotributylamine to research their effect on the used configurations.  
3. Testing the use of strictly perfluorotributylamine emulsion without any single walled 
carbon nanotubes. 
23 
 
4. Varying the amount of perfluorotributylamine emulsion and researching its effect on the 
previously used single walled carbon nanotube concentrations.  
5. Tensile and fatigue testing could be done to better understand the mechanical limitations 
of the current models.  
6. An in vivo study within an animal model could be conducted to get a real life application 
of the effects of mechanical strength and compatibility.  
7. A study on the incorporation of adipose derived stem cells and their ability to 
differentiate into various cell lines within the various scaffold configurations.  
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